Showing 6881-6890 of 20410 results for "".
Octane Aesthetics Tech Forum: Structural Adipose Tissue is Next Frontier
https://reachmd.com/conferences/octane-atf-2026/octane-aesthetics-tech-forum-structural-adipose-tissue-is-next-frontier/54707/At the 2026 Octane Aesthetics Tech Forum, Christopher Khorsandi, MD, board-certified plastic surgeon, and Chief Medical Officer of Tiger Aesthetics, joined the “Future of Aesthetics” panel to discuss what’s next for the field. In this video interview, he explains why structural adipose tissue couldChanging the Course of COPD: What’s New in Detection and Treatment
https://reachmd.com/programs/clinicians-roundtable/copd-detection-treatment-updates/54182/Significant advances in COPD management are redefining how clinicians detect and treat this chronic disease. Hear from Mr. Brian Bizik, a physician assistant and Respiratory Care Coordinator at Terry Reilly Health Centers in Idaho, as he shares key updates in COPD, including a new focus on disease aFood Allergies and Atopic Dermatitis in the Pediatric Population
https://reachmd.com/programs/dermatology-hub-neuroimmune-network/food-allergies-and-atopic-dermatitis-in-the-pediatric-population/37175/Elizabeth Lippner, MD, MA, Attending Physician in the Division of Allergy and Immunology and Assistant Professor of Pediatrics at Northwestern University Feinberg School of Medicine, discusses potential links between food allergies and pediatric atopic dermatitis, and how to address them.Applying Real-World Data from SABCS 2025 to HR+ HER2- Breast Cancer Care
https://reachmd.com/programs/project-oncology/real-world-data-sabcs2025-breast-cancer-care/36165/Real-world evidence presented at the 2025 San Antonio Breast Cancer Symposium (SABCS) is helping to identify treatment gaps and guide clinical decision-making for hormone receptor-positive, HER2-negative (HR+ HER2-) advanced breast cancer. From advances in ESR1 testing to explorations of frontline CAdvances in ATTR-CM: Evolving Diagnostics and Therapeutics
https://reachmd.com/programs/clinicians-roundtable/advances-attr-cm-diagnostics-therapeutics/49055/In the past decade, significant strides have been made in diagnosing and treating patients with transthyretin amyloid cardiomyopathy (ATTR-CM). Increased disease awareness, non-invasive diagnostic tools like scintigraphy, and AI-assisted screening have led to earlier detection and improved outcomes.Expert Opinions on Characteristics of Patients With C3G at High Risk of Progression
https://reachmd.com/programs/medical-industry-feature/c3g-high-risk-progression-characteristics/39255/A variety of indicators can help provide important information on disease progression in patients with complement 3 glomerulopathy (C3G). Hear from Drs Dana Rizk, Carla Nester, Sanjeev Sethi, and Leal C. Herlitz as they share their perspectives. Dr Rizk is a Professor of Medicine in the Division ofThe Hidden Respiratory Burden of Obesity: Understanding the Clinical Consequences
https://reachmd.com/programs/clinicians-roundtable/the-hidden-respiratory-burden-of-obesity-understanding-the-clinical-consequences/39650/Obesity introduces distinct changes to respiratory physiology that ripple across care settings—from subtle outpatient symptoms to complex ventilatory challenges in the ICU and heightened perioperative risks. Dr. Sujith Cherian explains real-world scenarios and physiologic insights to show how excessExploring Tafamidis Survival Data in Elderly Patients with ATTR-CM
https://reachmd.com/programs/Audioabstracts/survival-elderly-patients-attr-cm-tafamidis/49053/A new analysis from the HEAR registry revealed that tafamidis is associated with significantly improved three-year survival in patients aged 80 and older with transthyretin cardiac amyloidosis (ATTR-CM). Hear from Dr. Hallie Blevins as she discusses this large real-world dataset and the importance oUnmet Needs in Atopic Dermatitis Management
https://reachmd.com/programs/dermatology-hub-neuroimmune-network/unmet-needs-in-atopic-dermatitis-management/37145/Practical Dermatology Chief Medical Editor Neal Bhatia, MD, FAAD, a board-certified dermatologist in San Diego, California, and Director of Clinical Dermatology at Therapeutics Clinical Research, says the most pressing unmet needs in atopic dermatitis management today involve the targets of therapyFace Value with Modern Aesthetics: Dr. Lisa Espinoza Debunks Misinformation Surrounding HA fillers
https://reachmd.com/series/face-value/face-value-with-modern-aesthetics-dr-lisa-espinoza-debunks-misinformation-surrounding-ha-fillers/49192/Lisa Espinoza, MD, discusses the Naturally You with Injectable Hyaluronic Acid Fillers report—and how she will incorporate this data with patients interested in HA fillers.